evidence indicates that u-3 fatty acids derived from fish oils, such as docosahexanoic acid (DHA) and eicosapentanoic acid (EPA), have an anti-inflammatory effect (Serhan et al., 2008) .
To sort out the metabolic impact of various types of fatty acids, Oh et al. characterized the tissue expression patterns of five G protein-coupled receptors (GPCRs) known to bind and respond to fatty acids. Among these receptors, GPR120 was the only one with an expression profile that correlated well with a potential role in regulating metabolism. They found that GPR120 is highly expressed in adipose tissue macrophages, fat cells, and specialized macrophages in the liver called Kupffer cells. Moreover, a high-fat diet increases the expression of this receptor on macrophages, suggesting that GPR120 might be controlled by inflammatory signals.
GPR120 is an orphan receptor for which no endogenous ligands are known. Using a heterologous reporter system, Oh et al. now find that the u-3 fatty acids DHA, EPA, and palmitoleate are agonists of GPR120. Furthermore, activation of GPR120 by DHA antagonizes the proinflammatory effects of TNFa and lipopolysaccharide in a macrophage cell line. DHA not only blocks the NFkB and JNK pathways but also prevents expression of cytokines (Figure 1 , bottom right).
GPR120 is known to couple with the G q/11 family of G proteins. After ligand binds and G q/11 is released, G protein receptor kinases phosphorylate the receptor. This generates binding sites for b-arrestins, which mediate internalization and downregulation of the receptors. However, b-arrestins can also interact with downstream signaling molecules (Rajagopal et al., 2010) . In a series of gene silencing experiments, Oh and colleagues demonstrate that b-arrestin2 is essential for the anti-inflammatory effects of u-3 fatty acids in macrophage cells, but G q is surprisingly dispensable for this process. Moreover, b-arrestin2 inhibits both the JNK and NF-kB pathways by sequestering the TAK1 binding protein TAB1. The inhibition of TAB1 prevents phosphorylation and thus activation of IkB kinase upstream of NFkB and MKK4 (mitogen-activated protein kinase kinase 4) upstream of JNK.
These new insights into the sensing and signaling of GPR120 offered Oh and colleagues a unique opportunity to study the molecular mechanisms underlying the metabolic benefits of u-3 fatty acids in vivo. First, Oh and colleagues establish that the high-fat diet given to mice in the laboratory is low in u-3 fatty acids. They then show that supplementing this diet with DHA and EPA reverses the deleterious effects that the high-fat diet has on glucose homeostasis and lipid storage (i.e., steatosis). Although the authors do not address whether u-3 fatty acids can prevent insulin resistance or glucose intolerance in mice, they do demonstrate that DHA and EPA reverse insulin resistance caused by the high-fat diet. Moreover, disruption of the GPR120 gene abolishes the benefits of u-3 fatty acids on glucose homeostasis and insulin sensitivity in mice. These results demonstrate the crucial role GPR120 plays in the metabolic benefits of DHA and EPA. Interestingly, mice receiving bone marrow transplants from the GPR120-deficient mice are also resistant to the beneficial properties of DHA and EPA. Thus, the u-3 fatty acids appear to act primarily through macrophages.
Taken together with previous data, these findings from Oh and colleagues support a model in which dietary fatty acids control the inflammatory properties of macrophages in adipose tissue by regulating the activity and expression of opposing receptors (Figure 1 ). With a normal diet containing a balanced ratio of saturated and u-3 unsaturated fatty acids, anti-inflammatory M2 macrophages protect adipose cells by dampening excess inflammation and maintaining insulin sensitivity of fat cells (Lumeng et al., 2007) . When mice are given a high-fat diet with excess calories and little u-3 fatty acids, TLR4 is left unchecked in fat cells. The activated receptor induces expression and release of chemokines, such as MCP-1 (monocyte chemotactic protein-1), which then recruit proinflammatory M1 macrophages into adipose tissue (Lumeng et al., 2007) .
These cells produce cytokines, such as TNFa, which further activate the macrophages and attenuate insulin action in adipocytes. Eventually, this leads to local and then systemic insulin resistance. However, these activated M1 macrophages also express elevated levels of GPR120. Thus, addition of u-3 fatty acids to the diet stimulates GPR120 and initiates a signaling pathway through b-arrestin2, which blocks the effects of TLR4 and inflammatory cytokine receptors. This reduces the inflammatory state of these cells and simultaneously promotes the return of anti-inflammatory M2 macrophages to adipose tissue, which leads to the restoration of insulin sensitivity.
This model raises many new questions about the crosstalk between adipose tissue and immune cells in obesity. First, could GRP120 activation serve as a homeostatic mechanism in macrophages to resolve inflammation in obese animals? If so, then what controls GPR120 expression, and what is its physiological role in adipose and liver tissue? Also, does GPR120 respond to endogenous ligands to control macrophage activity? Although the new study by Oh and colleagues explains how activation of GPR120 inhibits inflammatory pathways, it is still unknown how this receptor increases the presence of anti-inflammatory M2 macrophages in adipose tissue and from where these cells arise. Do M2 macrophages (or their precursors) express GPR120 in order to develop or maintain the anti-inflammatory phenotype, or does activation of GPR120 induce the transdifferentiation of inflammatory M1 macrophages to anti-inflammatory M2 macrophages in situ?
Finally, previous studies demonstrate that fish oils have diverse benefits on multiple tissues. For example, u-3 fatty acids can inhibit the production of proinflammatory eicosanoids and serve as precursors for resolvins, (i.e., protective lipids that help reduce inflammation) (Serhan et al., 2008) . In addition, fish oils help prevent cardiovascular disease and have positive effects on many inflammatory disorders, such as arthritis, asthma, and ulcerative colitis. Is GPR120 the only receptor responsible for these various benefits? Future studies are also needed to determine whether dietary supplements and ingestion of fatty fish can provide high enough concentrations of circulating u-3 fatty acids to promote GPR120 activation. Nevertheless, the new insights presented by Oh and colleagues into the anti-inflammatory mechanisms of u-3 fatty acids provide a platform for investigating these important questions. Plus, the identification of GPR120 pinpoints a new therapeutic target for treating the inflammatory state associated with obesity and type 2 diabetes. This alone is cause for a bit of excitement.
Figure 1. A Model for How u-3 Fatty Acids Preserve Insulin Sensitivity through GPR120
A high-fat diet with a disproportionate ratio of saturated fatty acids to u-3 fatty acids triggers activation of Toll-like receptor 4 (TLR4) in adipocytes and circulating immune cells. This launches an inflammatory cascade that results in the recruitment of proinflammatory M1 macrophages, increased secretion of TNFa, and insulin resistance in adipocytes. The addition of u-3 fatty acids to the diet activates the G protein-coupled receptor GPR120 on proinflammatory M1 macrophages (Oh et al., 2010) , which in turn attenuates the inflammatory response and recruits anti-inflammatory M2 macrophages to adipose tissue. Eventually, these M2 macrophages restore secretion of interleukin-10 and improve insulin sensitivity.
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The generation of planar cell polarity (PCP) and tissue shape during morphogenesis is tightly linked, but it is not clear how. Aigouy et al. (2010) now show in the developing Drosophila wing that PCP initially has a radial orientation that becomes realigned to the proximal-distal axis of organ shape by mechanical forces and cell rearrangements mediated by Dachsous.
Most tissues and organs composed of and organized as epithelial cell layers display, in addition to the common apical-basal epithelial polarity, a polarity within the epithelial plane. This is commonly referred to as planar cell polarity (PCP). Genetic studies in the fruit fly Drosophila melanogaster have established that there are two molecular systems coordinating the cellular asymmetries in the plane of tissues. These include the Frizzled/PCP signaling pathway containing the VanGogh (Vang, also known as Strabismus/ Stbm) protein and other factors (Strutt, 2003; Seifert and Mlodzik, 2007 ) and a pathway mediated by the protocadherins Fat and Dachsous (Lawrence et al., 2007) . Although the molecular relationships between these two systems are unclear, there is strong evidence that they act in parallel, probably affect different effectors, and may compensate for each other in some tissues (Lawrence et al., 2007; Wu and Mlodzik, 2009 ).
In the developing Drosophila wing, cellular asymmetries in the plane of the epithelium are first detected at later pupal stages along the proximal-distal axis (at around 24-30 hr after puparium formation). The core Frizzled/PCP factors form two distinct complexes that become localized asymmetrically to either the proximal (Vang/Stbm and associated proteins) or the distal side of pupal wing cells (Frizzled and associated proteins). These complexes are stabilized by feedback loop interactions among themselves (Seifert and Mlodzik, 2007; Strutt, 2003) . In addition, Frizzled and Vang/Stbm protein complexes may be required earlier to coordinate global tissue polarity/PCP within the wing epithelium (Classen et al., 2005; Wu and Mlodzik, 2009) .
Supporting this idea, the new study by Aigouy et al. (2010) in this issue of Cell helps to establish that subcellular asymmetries among the Frizzled/PCP core group proteins are already present at early pupal stages during wing development (14-15 hr after puparium formation or earlier). Strikingly, the Frizzled/PCP complexes display radial polarity that is perpendicular to the wing margin ( Figure 1A) , confirming that coordination of global Frizzled/PCP signaling is established early in pupal fly wings. The authors further demonstrate that these early asymmetries indeed depend on FrizzledVang/Stbm signaling as the nonautonomous behavior of frizzled mutant cell patches (clones) affecting the polarity of wild-type cells flanking the frizzled mutant cells (Vinson and Adler, 1987) is already observed at this stage. Strikingly, in contrast to the nonautonomous effects observed at the distal side of frizzled mutant cell patches in late pupal and adult wings (Vinson and Adler, 1987) , early frizzled clones influence the polarity of wildtype cells residing between the wing margin and the clone within the radial polarity axis. This confirms a ''signaling axis'' toward the wing margin at early stages. Taken together, the observations of Aigouy et al. (2010) indicate that (1) PCP, mediated by Frizzled-Vang/Stbm signaling, is established during latelarval/early-pupal stages in a radial axis perpendicular to the margin and (2) the polarity/PCP seen in the adult wing is a result of cellular rearrangements during wing morphogenesis within the proximal-distal axis that are dependent on Dachsous.
How is polarity realigned along the proximal-distal axis as morphogenesis proceeds? As PCP is already established
